is trulicity a semaglutide or tirzepatide vs Switch to Tirzepatide in T2D

They promise the benefits of modern medicine without the needles or strict regulations

Eric Levin, CEO Apr 9, 2025 4 min read In the world of chronic disease and weight management, few breakthroughs have generated as much excitementor delivered as much promiseas GLP1-s

Now, 68% of users are taking GLP1s specifically to lose weight These drugs are fundamentally disrupting how people engage with food and drink. A structural shock to grocery The research reveals a dramatic contraction in grocery purchasing among GLP1 users: 780 million has been removed from Britains grocery receipts 299 million fewer packs have been purchased User households spend 418 less per year than nonuser households More than half of users (54%) report fewer cravings and reduced food noise, while one in ten (11%) say they no longer enjoy their usual food and drink favourites

2: receiving maximum dose 1 mg